| 000 | 01763cas a2200433 a 4500 | ||
|---|---|---|---|
| 001 | 17110697 | ||
| 003 | OSt | ||
| 005 | 20180116183020.0 | ||
| 008 | 091020c200u9999enkmr p 0 a0eng | ||
| 010 | _a 2013207038 | ||
| 022 | _y0960-5002 | ||
| 035 | _a(OCoLC)ocn457232064 | ||
| 040 |
_aNNCGS _beng _cNNCGS _dNNCGS _dOCoLC _dSiSiNL _dOCoLC _dDLC _dOCLCO _dDLC |
||
| 042 | _alccopycat | ||
| 050 | 0 | 0 |
_aK1519.B54 _bM337 |
| 082 | 0 | 4 |
_a346.048 SOP 2014 _222 |
| 100 | _aVinod V. Sople | ||
| 245 | 0 | 0 |
_aManaging intellectual property. _bThe Strategic Imperative |
| 246 | 1 |
_iIssues for <2012-> have title: _aManaging intellectual property. _pNBSIntellectual property focus. _pNBSLife sciences |
|
| 246 | 1 |
_aIP focus. _pNBSLife sciences |
|
| 246 | 1 |
_aIntellectual property focus. _pNBSLife sciences |
|
| 246 | 1 | _aLife sciences | |
| 250 | _a4 th Ed. | ||
| 260 |
_aLondon : _bEuromoney Institutional Investor PLC, _c2014 |
||
| 300 |
_a424 p. _bill., ports. ; _c26 cm. |
||
| 310 | _a10 times a year | ||
| 440 | _aManaging Intellectual Property | ||
| 500 | _aIssued as special supplement to: Managing intellectual property. | ||
| 600 | _aVinod V. Sople | ||
| 650 | 0 |
_aPatent laws and legislation _vPeriodicals. |
|
| 650 | 0 |
_aBiotechnology industries _xLaw and legislation _vPeriodicals. |
|
| 650 | 0 |
_aBiotechnology _vPatents _vPeriodicals. |
|
| 710 | 2 | _aEuromoney Institutional Investor PLC. | |
| 730 | 0 | _aManaging intellectual property. | |
| 906 |
_a7 _bcbc _cserasst _d2 _encip _f20 _gn-oclcserc |
||
| 942 |
_2ddc _cBK |
||
| 999 |
_c350527 _d350527 |
||